The New York City Department of Health and Mental Hygiene is investigating a possible monkeypox case.
A patient being treated at Bellevue Hospital could potentially have the rare illness.
The announcement comes one day after health officials identified a monkeypox case in Massachusetts.
New York City reports first suspected case of monkeypox
— BNO News Live (@BNODesk) May 19, 2022
Days after unusual clusters of the rare monkeypox virus emerged in Europe, New York City health authorities announced on Thursday that they were investigating a possible case of the rare disease. https://t.co/imnmmtfPCT
— The New York Times (@nytimes) May 20, 2022
ABC 7 reported:
Outside of Africa, cases of monkeypox are relatively rare, but right now, there are about a hundred suspected or confirmed cases in eight countries outside Africa, including the United States.
There are currently six Americans being monitored by the CDC for the illness. They were all on the same flight as a British person who tested positive for monkeypox earlier this month.
The disease is similar to chickenpox and smallpox but less contagious, according to the CDC.
The virus starts out with a fever and a rash, usually on the face, but it spreads. Muscle and backaches follow, along with chills and extreme fatigue.
Most people recover in less than a month, but it can be fatal in up to 6% of the people who contract it.
Fox News added:
The patient is being cared for at NYC Health + Hospitals/Bellevue, according to health officials. The department said preliminary tests will be sent to the Centers for Disease Control and Prevention (CDC) if they come out positive.
The city’s health department did not say whether the unidentified patient had traveled anywhere outside the United States.
The news came a day after Massachusetts health officials confirmed the first case of monkeypox in the U.S. this year. The individual had recently traveled to Canada and officials were conducting contact tracing.
With the latest reports of monkeypox, I must ask this question.
Could Scamdemic 2.0 be upon us?
Here’s the latest coverage that should raise some eyebrows: